Ownership history in BARCLAYS PLC · 14 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 50,251 | +42,251 | +528.1% | 0.00% | $662K | $13.18 |
| 2025 Q3 | ADDED | 8,000 | +7,984 | +49900.0% | 0.00% | $57K | $7.17 |
| 2025 Q3 | REDUCED | 16 | -4,537 | -99.6% | 0.00% | $115 | $7.17 |
| 2025 Q2 | REDUCED | 4,553 | -15,046 | -76.8% | 0.00% | $215K | $47.20 |
| 2025 Q1 | ADDED | 19,599 | +14,953 | +321.8% | 0.00% | $766K | $39.07 |
| 2024 Q4 | REDUCED | 4,646 | -995 | -17.6% | 0.00% | $252K | $54.15 |
| 2024 Q3 | ADDED | 5,641 | +5,229 | +1269.2% | 0.00% | $283K | $50.42 |
| 2024 Q2 | REDUCED | 412 | -3,367 | -89.1% | 0.00% | $18K | $43.97 |
| 2024 Q1 | REDUCED | 3,779 | -2,335 | -38.2% | 0.00% | $190K | $50.23 |
| 2023 Q4 | ADDED | 6,114 | +2,802 | +84.6% | 0.00% | $369K | $60.39 |
As of 2025 Q4 — sorted by position size